Review of the molecular mechanisms of Ganoderma lucidum triterpenoids: Ganoderic acids A, C2, D, F, DM, X and YChengyuan Liang, Juan Xia, Han Li et al.|European Journal of Medicinal Chemistry|2019Cited by 192
The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-reviewChengyuan Liang, Suresh Thareja, Danni Tian et al.|European Journal of Medicinal Chemistry|2018Cited by 168
Bruton’s tyrosine kinase (BTK) inhibitors in treating cancer: a patent review (2010-2018)Yifan Feng, Minhang Xin, Chengyuan Liang et al.|Expert Opinion on Therapeutic Patents|2019Cited by 59